Загрузка...
MET in gastric cancer – discarding a 10% cutoff rule
AIMS: We aimed to develop a putative predictive biomarker score for future hepatocyte growth factor receptor (MET)‐targeted therapy of gastric cancer (GC). METHODS AND RESULTS: MET expression and MET amplification were analysed by immunohistochemistry (IHC) and chromogenic in‐situ hybridization (CIS...
Сохранить в:
| Опубликовано в: : | Histopathology |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
John Wiley and Sons Inc.
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4744765/ https://ncbi.nlm.nih.gov/pubmed/26033401 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/his.12745 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|